Free Trial
OTCMKTS:BICX

Biocorrx Q4 2024 Earnings Results & Report

Biocorrx logo
$0.21 0.00 (0.00%)
As of 11/13/2026 10:26 AM Eastern

Biocorrx reported Q4 2024 earnings on March 31, 2025. The company reported EPS of -$0.08.

Earnings Announcement Details

Quarter
Q4 2024
Report Date
Time
After Market Closes

Biocorrx EPS Results

Actual EPS
-$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 4 quarters

Biocorrx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

Biocorrx Q4 2024 Earnings FAQ

Biocorrx (OTCMKTS:BICX) reported earnings of -$0.08 per share for Q4 2024. The report was announced on Monday, March 31, 2025.

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biocorrx on the company's earnings history page.

Biocorrx Earnings Headlines

Biocorrx (BICX) Projected to Release Quarterly Earnings on Tuesday
BioCorRx Inc
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
BioCorRx Inc.
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence.

The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

BioCorRx has also offered UnCraveRx, a medically supervised weight-management program. Its activities are centered on treatment and support services rather than traditional pharmaceutical manufacturing or general medical care.

View Biocorrx Profile